Form 4: SCYNEXIS CFO Ivor Macleod Acquires Shares and Options

SCYNEXIS Chief Financial Officer Ivor Macleod acquired shares and stock options on January 23, 2025, according to a recent SEC filing.

Summary

• Ivor Macleod, the Chief Financial Officer of SCYNEXIS Inc., reported a transaction on January 23, 2025.
• Macleod acquired 92,511 shares of common stock at a price of $0.
• He also acquired 138,767 employee stock options with an exercise price of $1.08.
• The stock options vest monthly over 48 months starting January 23, 2025.
• The restricted stock units vest one third per year over three years starting February 28, 2025.
• Following these transactions, Macleod directly owns 260,696 shares of common stock and 138,767 stock options.

Sentiment

Score: 6

Explanation: The document is a routine SEC filing detailing insider transactions, which is neither particularly positive nor negative. It is a neutral event.

Positives

• The acquisition of shares and options by the CFO could be seen as a positive sign of confidence in the company's future.

Industry Context

This filing is a routine disclosure of insider transactions, which is common in publicly traded companies. It provides transparency into the holdings of company executives.

Comparison to Industry Standards

• The vesting schedule for the stock options and restricted stock units is typical for executive compensation packages in the biotechnology industry.
• The acquisition of shares at $0 is likely due to the grant of restricted stock units as part of the executive's compensation.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to the CFO's increased stake in the company.

Key Dates

Keywords

SEC Form 4, SCYNEXIS, Insider Trading, Stock Options, Restricted Stock Units, Ivor Macleod, Chief Financial Officer, Equity Compensation